Skip to main content
Home
  • The Network
    • Membership
    • Cambridge Cluster
    • Moments that made the Cambridge Cluster
    • Who we are
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Promote your event
  • Learning
    • Training courses
    • CN eLearning
    • In-house courses
    • Peer learning
    • Cambridge Judge Business School
    • Make an enquiry
  • Jobs
    • Jobs listing
    • Advertise your vacancies
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Cambridge Cluster
      • Membership
      • The moments that made us
      • Who we are
    • Companies
      • Member directory
      • Blog
    • News
      • News listing
    • Events
      • Events listing
      • Promote your event
    • Learning
      • Training courses
      • CN eLearning
      • In-house courses
      • Peer learning
      • Cambridge Judge Business School
      • Make an enquiry
    • Jobs
      • Jobs listing
      • Advertise your vacancies
      • Tips for finding a job
    • Contact us

    Breadcrumb

    1. Home
    2. News
    3. Search results
    Displaying results 1 - 25 of 170 Clear search
    Zyme Communications
    Healthcare and Life Science 23 Jun 2022

    FUJIFILM Irvine Scientific acquires exclusive license for artificial intelligence for IVF

    Santa Ana, Calif., FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell culture media and assisted reproductive technologies (ART), announces it has exclusively licensed the intellectual property relating to artificial intelligence (AI) for image-based evaluation of human embryos to improve in-vitro fertilization (IVF) success rates

    Zyme Communications
    Matt Segall, CEO, Optibrium
    Healthcare and Life Science 21 Jun 2022

    Optibrium receives further investment from Kester Capital

    Cambridge UK - Optibrium™, a developer of software for drug discovery, announces it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm.

    Zyme Communications
    Lightbench Detect by Yourgene
    Healthcare and Life Science 20 Jun 2022

    Yourgene Health Launches LightBench Detect for Fetal Fraction Enrichment

    Manchester, UK - Yourgene Health plc, a leading international molecular diagnostics group, announces the launch of the LightBench® Detect, the latest addition to its Ranger® Technology instrumentation portfolio at the 26th International Conference on Prenatal Diagnosis and Therapy (ISPD).

    Zyme Communications
    Healthcare and Life Science 15 Jun 2022

    Global Access Diagnostics (GADx) formed to expand affordable access to advanced rapid diagnostic technologies

    Bedford, UK - Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, formally introduces its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in the global provision of diagnostics with a focus on expanding affordable access to quality tests.

    Zyme Communications
    Dr Amy Liao, Board Member, seqWell
    Healthcare and Life Science 15 Jun 2022

    seqWell appoints Dr Amy Liao to Board of Directors

    Beverly, Mass  – seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, announces the appointment of Dr Amy Liao to its Board. Amy joins the current Board of Directors, led by Chairman Paul McEwan. The appointment supports the commercial development of the Company’s existing and future products, following…

    Zyme Communications
    Dr Myriam Ouberai, CEO, Spirea
    Healthcare and Life Science 14 Jun 2022

    Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer

    Cambridge - Spirea Limited, a Cambridge company created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has announced that it has secured funding of £2.4 million with investments from high-profile UK and US investors. Spirea will use the funds to initiate its pipeline of superior and differentiated ADCs in the treatment of solid tumours where there is a high unmet need.

    Zyme Communications
    Bio-Rad Foresight Pro Columns
    Healthcare and Life Science 13 Jun 2022

    Bio-Rad Launches Foresight Pro Columns for Biotherapeutic Production

    Helcules, Calif. - Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announces the launch of its CHT™ prepacked Foresight Pro Columns, designed to support downstream process-scale chromatography applications across different stages of biological drug development and production. 

    Zyme Communications
    Healthcare and Life Science 13 Jun 2022

    Innovate UK awards grant to Orbit Discovery to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery

    The project will use microfluidic technology to improve efficiency of peptide therapeutics discovery for challenging drug targets.

    Zyme Communications
    Dr Benedetta Montagnini Head of European Business Development, Metrion Biosciences
    Healthcare and Life Science 09 Jun 2022

    Metrion Biosciences appoints Dr Benedetta Montagnini as Head of European Business Development

    Expansion of European business development team supports next phase of growth for Metrion’s ion channel drug discovery services

    Zyme Communications
    Matt Segall, CEO, Optibrium
    Healthcare and Life Science 08 Jun 2022

    Optibrium expands UK head office with new facilities on Cambridge Innovation Park

    Optibrium™, a developer of software for drug discovery, announces the expansion of its UK headquarters with a move to larger office premises on Cambridge Innovation Park North. The new facilities accommodate Optibrium's accelerated growth and ongoing recruitment efforts to support the continued success and development of the company's innovative technology focused on improving the efficiency and…

    Zyme Communications
    Bio-Rad SEQuoia Express Stranded RNA Library Prep Kit
    Healthcare and Life Science 07 Jun 2022

    Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022

    Hercules, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announces the launch of the SEQuoia Express Stranded RNA Library Prep Kit. The kit provides biopharmaceutical and research scientists with an easy-to-use solution for constructing robust libraries to support efficient RNA-Seq workflows for comprehensive…

    Zyme Communications
    www.dotmatics.com
    Healthcare and Life Science 06 Jun 2022

    Dotmatics strengthens leadership team as it continues to invest in organization capabilities and accelerate growth

    Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making, announces the addition of Larry Samuelson as Chief Legal Officer and Neil Frye as Chief People Officer. The appointments further bolster the company’s executive team as the company extends the reach of its research and data solutions globally.

    Zyme Communications
    Joe Mellor, Co-founder and Chief Scientific Officer, seqWell
    Healthcare and Life Science 31 May 2022

    seqWell and Element Biosciences partner to demonstrate sequencing performance of multiplexed plexWell technology with the AVITI System

    Beverly, Mass. And San Diego, Calif., - seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, announces a partnership with Element Biosciences Inc., developer of the Element AVITI™ System.

    Zyme Communications
    Bio-Rad CFX Duet System
    Healthcare and Life Science 27 May 2022

    Bio-Rad launches CFX Duet Real-Time PCR System

    Hercules, Calif. – Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announces the launch of the CFX Duet Real-Time PCR System to support researchers in developing singleplex and duplex quantitative PCR (qPCR) assays.

    Zyme Communications
    Dr Paul Brooks Chief Business Officer CN Bio
    Healthcare and Life Science 24 May 2022

    CN Bio appoints Dr Paul Brooks as Chief Business Officer

    Cambridge, UK : CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), announces the appointment of Dr Paul Brooks as Chief Business Officer.

    Zyme Communications
    Healthcare and Life Science 18 May 2022

    FUJIFILM Irvine Scientific completes construction of Bioprocessing Innovation and Collaboration Center in China

    New center opens in Suzhou New District, China, to bring local cell culture media optimization support for vaccines, advanced therapies, and biotherapeutic drug development.

    Zyme Communications
    Umicore Corporate R&D scientists in the laboratory
    Healthcare and Life Science 17 May 2022

    Dotmatics supports Umicore Corporate R&D in processing of experimental data

    Boston, MA, Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, announces it has been selected by Umicore Corporate Research and Development, which is part of global materials technology and recycling company Umicore, as informatics partner for its Corporate R&D (CRD) digitalization project.

    Zyme Communications
    Healthcare and Life Science 16 May 2022

    AffyXell expands its strategic partnership with GenScript ProBio

    London and Wetherby, UK: Avacta Group plc, a clinical stage oncology drug company developing innovative cancer therapies and powerful diagnostics based on its proprietary pre|CISION™ and Affimer® platforms, is pleased to announce that AffyXell, its joint venture with South Korean drug maker Daewoong Pharmaceutical, has expanded its strategic partnership with GenScript ProBio, a leading…

    Zyme Communications
    Healthcare and Life Science 11 May 2022

    Avacta establishes new Therapeutics headquarters at Scale Space, Imperial College White City Campus

    London and Wetherby, UK, Avacta Group plc, a clinical stage oncology drug company developing innovative cancer therapies and powerful diagnostics based on its proprietary pre|CISION™ and Affimer® platforms, announces that the Company has relocated its Therapeutics division to a new headquarters at Scale Space, in Imperial College’s White City Campus, London.

    Zyme Communications
    Denise Emsden
    Healthcare and Life Science 10 May 2022

    Sphere Fluidics strengthens commercial team with three new senior hires

    Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announces that it has appointed three new hires to its commercial team. Evelyn Stevenson and Ravi Girdhar join as Director of Product Management and Director of Sales (EMEA), respectively, alongside Denise Emsden as Vice-President of People and Organizational Development.

    Zyme Communications
    Dan Calvo
    Healthcare and Life Science 09 May 2022

    seqWell’s plexWell technology selected by California Conservation Genomics Project for conservation genomics research

    Beverly, Mass. and Los Angeles, Calif, seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ multiplexing platform, announces a partnership with California Conservation Genomics Project (CCGP).

    Zyme Communications
    chip carrier
    Healthcare and Life Science, Manufacturing 09 May 2022

    Evonetix granted patent for binary assembly method for gene synthesis

    Evonetix Ltd, the synthetic biology company bringing semiconductor technology to DNA synthesis, announces it has been granted a European patent covering its unique Binary Assembly method for gene synthesis.

    Zyme Communications
    Mike Mckee
    Healthcare and Life Science, Science and Engineering 03 May 2022

    Dotmatics biology solution for antibody discovery streamlines data collection and workflows to accelerate antibody research and therapies

    Boston, MA - Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, announces the release of its Biology Solution for Antibody Discovery, a unique end-to-end software and data management package.

    Zyme Communications
    Thomas Swalla, CEO of Dotmatics
    26 Apr 2022

    Dotmatics, previously Insightful Science, set to transform the future of scientific software and data management

    Boston, MA, — Dotmatics is announced as the formal name and brand for the combined entities of Insightful Science and Dotmatics. As the Insightful Science brand is retired, the new Dotmatics company is now inclusive of the Dotmatics’ enterprise scientific platform and many of scientists’ favorite applications including SnapGene, Geneious, and GraphPad Prism to offer end-to-end solutions for…

    Zyme Communications
    CN Bio’s PhysioMimix™ microphysiological system
    26 Apr 2022

    CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

    CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), introduces its PhysioMimix™ ‘in-a-box’ reagent kit for Non-alcoholic steatohepatitis (NASH), the most severe form of non-alcoholic fatty liver disease (NAFLD).

    Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • …
    • Next page ›
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    © 2022 Cambridge Network. All Rights Reserved.

    Website by KISS